Navigation Links
Clearing the 'fog'
Date:1/15/2009

Many of the side effects from chemotherapy are well documented: Fatigue, nausea and hair and weight loss. But there is another one that has split the medical community about whether is even exists. It's called chemotherapy-induced cognitive deficits or "chemo fog" and pharmacologist Ellen Walker hopes her research not only proves its real, but finds the cause.

Walker, a PhD and associate professor of pharmacodynamics at the School of Pharmacy, received a $1.5 million dollar National Institutes of Health grant at the beginning of this year to study the possible effects of drugs used during chemotherapy on cognitive impairment. It's a big grant, with perhaps even bigger implications for how researchers and patients deal with chemotherapy-induced cognitive deficits, which chemotherapy patients liken to being in a fog, as if they're brain isn't working right. Misplaced items, inability to multi-task, short-term memory loss are hallmarks of the condition. And while there is clinical evidence to support its existence, research studies on the topic are scant.

"My colleague Bob Raffa and I were stunned at the lack of published literature, considering cancer patients have been getting chemotherapy for nearly 50 years," said Walker. "Most studies have looked at how well chemotherapeutic agents kill the tumor, not if they cause a cognitive deficiency, like memory loss."

Walker and Raffa decided to fill that void. Two years ago, Walker and PharmD student John Foley, set out to see if certain chemotherapeutic agents caused memory and learning deficits in mice. They tested two older drugs commonly used to treat breast cancer, a cancer with recently higher survival rates whose survivors have dominated the limited clinical research on chemotherapy-induced cognitive deficits. They suspected the drugs, methotrexate and 5-fluorouracil, weren't toxic alone, but when given together, could cause deficits. Six months into their research, their hunch
'/>"/>

Contact: Megan Chiplock
chiplock@temple.edu
215-707-1731
Temple University
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Drexel School of Public Health Uses NetReachs cmScribe Advanced Content Management System (CMS) Software for First National Diversity Preparedness Clearinghouse
2. Blue Cross Blue Shield of Michigan Says Dont Let Snow Be a Pain: Ease into Clearing Sidewalks, Drives
3. Health IT Vendors, Clearinghouses Transforming Patient Insurance Verification Through CAQH National Initiative
4. New Device for Clearing Blocked Arteries in the Legs Receives FDA Clearance for Peripheral Use - Procedures Performed Across the US Within First 48 Hours
5. After ER visit, many patients in a fog, U-M study finds
6. New Software Program Helps Breast Cancer Survivors and Patients Fight Chemofog
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Clearing the 'fog'
(Date:2/26/2015)... Dallas, Texas (PRWEB) February 26, 2015 ... Hemostat Industry is a professional and in-depth study ... Hemostat industry with a focus on the ... market research are Lawton Gmbh & Co.KG, Hu-Friedy, ... Shanghai Medical Instruments, Shuangyin, Shanghai Weirong Medical Equipment, ...
(Date:2/26/2015)... February 26, 2015 “ KnowNote ” was ... features the latest and coolest mobile applications on the iOS, ... and host of NewsWatch, conducted the app review and shared ... staying in rhythm and in tune. , Learning a musical ... people. But what if people could take something they already ...
(Date:2/26/2015)... Claflin Medical Equipment , a ... Associates , a California based medical equipment distributor, have ... This merger joins two premier organizations that specialize in ... to any healthcare facility. By combining forces, they can ... and 31 service centers. Claflin will gain even greater ...
(Date:2/26/2015)... Today, Highmark Health announced that longtime board of ... as chairman of the board of directors and will ... of The PNC Financial Services Group, Inc. and president ... President and Chief Executive Officer David L. Holmberg will ... Highmark Inc.; both changes are effective as of Wednesday. ...
(Date:2/26/2015)... 26, 2015 Growth in the ... by a EuroMonitor International Report that U.S. men’s ... In response to the robust demand for ... launching a barbering program in partnership with internationally ... Factory” salon. The proprietary curriculum features 10 signature ...
Breaking Medicine News(10 mins):Health News:Global Hemostat Industry Data, Size and Growth Report 2015-2020 Now Available at DeepResearchReports.com 2Health News:Global Hemostat Industry Data, Size and Growth Report 2015-2020 Now Available at DeepResearchReports.com 3Health News:A Modern Way to Learn Music was Featured on NewsWatch Television on January 30, 2015 2Health News:Claflin Medical Equipment Announces Merger with Hospital Associates 2Health News:Highmark Health Appoints Joseph C. Guyaux Chairman of the Board of Directors 2Health News:Highmark Health Appoints Joseph C. Guyaux Chairman of the Board of Directors 3Health News:Highmark Health Appoints Joseph C. Guyaux Chairman of the Board of Directors 4Health News:Bellus Academy Partners with Renowned Hairstylist D.J. Muldoon to Launch Signature Barbering Program 2
... levels boosted mortality 25% in chronic kidney cases , , ... alkaline phosphatase -- a routinely measured marker of bone ... among patients receiving dialysis for chronic kidney disease, say ... 74,000 hemodialysis patients during a three-year period. It found ...
... Therapeutics,Inc. (Nasdaq: HALO ), a biopharmaceutical company ... that it will release financial results for the ... market open on Friday, August 8, 2008., ... Gregory Frost,PhD, Vice President and Chief Scientific Officer, ...
... ), a medical device company and a leader in cardiac surgical,ablation ... during August:, -- The BMO Focus on Healthcare Conference, ... Broadway Hotel in New York. David J. Drachman, President ... 9:00 a.m. Eastern time., -- The ...
... Minn. - The world-record pace for the marathon continues to ... pace for the marathon is now about as fast as ... War II. Today, champion athletes are running more than four ... mile. , How can this be? Are humans simply ...
... Foundation, the,philanthropic arm of AMERIGROUP Corporation, honored the ... a ceremony today at,the University of Maryland Medical ... Ancona presented a,contribution in the amount of $4,500 ... is a custom-built pediatric asthma and,allergy clinic that ...
... (NYSE: HLS ) has finalized, through ... announced purchase of The Rehabilitation,Hospital of South ... NJ, from The Mediplex/Cumberland Rehabilitation Limited,Partnership., ... the outstanding,leadership of Dr. Francis Bonner, has ...
Cached Medicine News:Health News:Bone Disease Test Shows Death Risk for Dialysis Patients 2Health News:Halozyme Therapeutics to Hold Pipeline Update Conference Call on August 8 2Health News:AtriCure to Present at the BMO Focus on Healthcare and Canaccord Adams Global Growth Conferences in August 2Health News:Story ideas for health reporters covering the summer Olympic Games 2Health News:Story ideas for health reporters covering the summer Olympic Games 3Health News:Story ideas for health reporters covering the summer Olympic Games 4Health News:Story ideas for health reporters covering the summer Olympic Games 5Health News:Story ideas for health reporters covering the summer Olympic Games 6Health News:The AMERIGROUP Foundation Honors the University of Maryland Hospital for Children's Breathmobile 2Health News:HealthSouth Finalizes Purchase of New Jersey Rehabilitation Hospital 2Health News:HealthSouth Finalizes Purchase of New Jersey Rehabilitation Hospital 3
(Date:2/26/2015)... February 26, 2015 ABIVAX, a clinical ... vaccines, today announced that it has dosed in ... IIb/III clinical trial of ABX203 which is taking place in ... The study is designed to assess whether ABX203 can deliver ... (CHB) via controlling viral load for a much longer period ...
(Date:2/26/2015)... 2015   HeartWare International, Inc . (NASDAQ: ... miniaturized circulatory support technologies that are revolutionizing the treatment ... million for the fourth quarter ended December 31, 2014, ... for the same period of 2013.  For the fiscal ... a 34% increase compared to revenue of $207.9 million ...
(Date:2/26/2015)... 26, 2015  Caris Life Sciences® today announced ... Genitourinary Cancers Symposium in Orlando, Fla. ... the Audio Poster Tour. Both studies utilized Caris ... service. These studies showed that panomic testing can ... carcinomas (RCC), providing insights that may drive selection ...
Breaking Medicine Technology:ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 2ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 3ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 4ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 5HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 2HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 3HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 4HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 5HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 6HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 7HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 8HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 9HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 10HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 11HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 12Caris Life Sciences' Multiplatform Tumor Profiling Helps to Identify Potential Predictive Biomarkers in Renal Cell Carcinoma 2Caris Life Sciences' Multiplatform Tumor Profiling Helps to Identify Potential Predictive Biomarkers in Renal Cell Carcinoma 3Caris Life Sciences' Multiplatform Tumor Profiling Helps to Identify Potential Predictive Biomarkers in Renal Cell Carcinoma 4Caris Life Sciences' Multiplatform Tumor Profiling Helps to Identify Potential Predictive Biomarkers in Renal Cell Carcinoma 5
... DATA ), a technology and services company focused ... reported its,operating results for the first quarter of 2008., ... revenue decreased,approximately 41% to $2,088,000 and the Company reported ... both a basic and diluted basis. These,results compared with ...
... data support potential of asenapine in the treatment of ... schizophrenia and bipolar I ... ) today announced that an overview of asenapine clinical trials,from ... of the,American Psychiatric Association in Washington, D.C., May 3-8. Data ...
Cached Medicine Technology:DATATRAK International Reports First Quarter Results for 2008 2DATATRAK International Reports First Quarter Results for 2008 3DATATRAK International Reports First Quarter Results for 2008 4DATATRAK International Reports First Quarter Results for 2008 5DATATRAK International Reports First Quarter Results for 2008 6DATATRAK International Reports First Quarter Results for 2008 7Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 2Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 3Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 4Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 5Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 6Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 7
Colloidal Gold Sol, 20 nm - 50 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
... PalmScan P2000 Pachymeter [i.e., PalmScan P2000] ... operated biometer, which incorporates A-mode pulsed-echo ... to accurately measure the corneal thickness ... eyes. PalmScan P2000 includes two software ...
... PalmScan A2000 A-Scan [i.e., PalmScan A2000] device ... which incorporates A-mode pulsed-echo ultrasound,technology, and thus ... axial length (AL), anterior,chamber depth (ACD), and ... PalmScan A2000,device is also intended for calculating ...
... low TLR (<1%) and stroke rate - ... long-term durability., , , High Radial Strength: ... artery, increasing lumen diameter with chronic outward ... stent shortening, low profile design, Cordis TRUMARK™ ...
Medicine Products: